Effect of Maternal Prenatal and Postpartum Vitamin D Supplementation on Offspring Bone Mass and Muscle Strength in Early Childhood: Follow-up of a Randomized Controlled Trial
Overview
Authors
Affiliations
Background: Maternal vitamin D status during pregnancy and lactation is a modifiable factor that may influence offspring musculoskeletal outcomes. However, few randomized trials have tested the effects of prenatal or postpartum vitamin D supplementation on offspring bone and muscle development.
Objectives: The aim was to examine hypothesized effects of improvements in early-life vitamin D status on childhood musculoskeletal health in Dhaka, Bangladesh.
Methods: In a previously completed, double-blind, dose-ranging trial, healthy pregnant women (n = 1300) were recruited at 17-24 weeks' gestation and randomly assigned to a prenatal/postpartum regimen of 0/0, 4200/0, 16,800/0, 28,000/0, or 28,000/28,000 IU cholecalciferol (vitamin D3)/wk until 26 wk postpartum. In this new report, we describe additional follow-up at 4 y of age (n = 642) for longer-term outcomes. Bone mineral content (BMC) and areal bone mineral density (aBMD) were measured by DXA. Grip strength was tested using a hand-held dynamometer. The primary comparison was children of women assigned to 28,000 IU/wk prenatally compared with placebo. Differences are expressed as means and 95% CIs.
Results: Total-body-less-head (TBLH) BMC, TBLH aBMD, and grip strength were similar in the combined high-dose prenatal (28,000/0 and 28,000/28,000 IU/wk) compared with placebo groups (mean difference [95% CI] = 0.61 g [-10.90, 12.13], 0.0004 g/cm2 [-0.0089, 0.0097], and 0.02 kg [-0.26, 0.31], respectively). In dose-ranging analyses, TBLH BMC and aBMD, whole-body BMC and aBMD, and grip strength in each of the prenatal vitamin D groups were not significantly different from placebo (P > 0.05 for all comparisons). Only head aBMD was greater in children of women assigned to the 28,000/28,000-IU regimen compared with placebo (mean difference [95% CI] = 0.024 g/cm2 [0.0009, 0.047], P = 0.042); the effect was attenuated upon adjustment for child height, weight, and sex (P = 0.11).
Conclusions: Maternal prenatal, with or without postpartum, vitamin D supplementation does not improve child BMC, aBMD, or grip strength at 4 y of age. The MDIG trial and present follow-up study were registered prospectively at www.clinicaltrials.gov as NCT01924013 and NCT03537443, respectively.
Watson K, Dasiewicz A, Bassani D, Chen C, Qamar H, OCallaghan K Curr Dev Nutr. 2024; 8(12):104495.
PMID: 39649476 PMC: 11621485. DOI: 10.1016/j.cdnut.2024.104495.
Gias M, Qamar H, Fariha F, Al Mahmud A, Shah P, Abrams S Public Health Nutr. 2024; 27(1):e265.
PMID: 39575549 PMC: 11705024. DOI: 10.1017/S1368980024002301.
Moon R, D Angelo S, Curtis E, Ward K, Crozier S, Schoenmakers I Am J Clin Nutr. 2024; 120(5):1134-1142.
PMID: 39306330 PMC: 11600048. DOI: 10.1016/j.ajcnut.2024.09.014.
Vitamin D supplementation for women during pregnancy.
Palacios C, Kostiuk L, Cuthbert A, Weeks J Cochrane Database Syst Rev. 2024; 7():CD008873.
PMID: 39077939 PMC: 11287789. DOI: 10.1002/14651858.CD008873.pub5.
Berry S, Josiane Honkpehedji Y, Ludwig E, Mahmoudou S, Prodjinotho U, Adamou R Sci Rep. 2024; 14(1):14845.
PMID: 38937587 PMC: 11211496. DOI: 10.1038/s41598-024-65232-9.